Willis Towers Watson: Portfolio Optimization and Margin Expansion Through Transformation
Grew margin 190bps to 23.9% and adjusted EPS 17% via WTW transformation.
Willis Towers Watson, a Large Enterprise Insurance Brokerage & Risk company, created value through Product Mix Shift and Sales, General, and Administrative (SG&A).
By 2022, Willis Towers Watson (WTW) faced margin pressure from its sprawling portfolio. The 2021 failed merger with Aon had left the company needing a new strategic direction. Its TRANZACT direct-to-consumer insurance distribution unit was diluting margins, and the company's adjusted operating margin lagged peers. WTW's two main segments — Health, Wealth & Career (HWC, 59% of revenue) and Risk & Broking (R&B, 41%) — needed operational streamlining to unlock profitability. Full-year 2023 revenue was $9.48 billion with an adjusted operating margin of 22.0%.
WTW launched a multi-year Transformation program focused on three pillars: (1) simplifying the operating model by consolidating technology platforms and standardizing processes across geographies; (2) optimizing the portfolio by divesting non-core assets, most notably selling TRANZACT in October 2024 for $632.4 million to GTCR and Recognize; and (3) driving organic growth through targeted investment in higher-margin advisory and broking capabilities. The Transformation program delivered $473 million in cumulative savings. In Risk & Broking, WTW invested in hiring productive talent while improving operating leverage, driving segment margins up 460 basis points in Q4 2024.
Full-year 2024 revenue reached $9.93 billion, a 4.7% increase from 2023, with 5% organic revenue growth. Adjusted operating margin expanded 190 basis points to 23.9% (24.4% excluding TRANZACT). Adjusted diluted EPS rose 17% year-over-year to $16.93. The R&B segment achieved 33.5% operating margin in Q4 2024. WTW is now targeting approximately 100 basis points of annual margin expansion through 2028, supported by completed Transformation savings and the margin-accretive TRANZACT divestiture.
Multi-year Transformation program with disciplined execution tracking. Willingness to divest a large business unit (TRANZACT) that diluted margins. Technology platform consolidation enabling process standardization. Targeted talent investment in Risk & Broking to drive organic growth alongside efficiency gains.
| Metric | FY2022 | FY2024 |
|---|---|---|
| Total revenue | ~$9.5B | $9.93B (+4.7% reported, +5% organic) |
| Adjusted operating margin | ~22.0% | 23.9% (+190 bps) |
| Adjusted operating margin (ex-TRANZACT) | — | 24.4% |
| Adjusted diluted EPS | — | $16.93 (+17% YoY) |
| R&B segment operating margin (FY2024) | — | 33.5% |
October 2024: TRANZACT divested to GTCR and Recognize for $632.4M.
TRANZACT was a direct-to-consumer Medicare insurance distribution business — a digital platform connecting Medicare-eligible individuals with insurance plan options. It was acquired by WTW in 2019 with the logic that digital distribution capabilities would complement WTW's traditional benefits advisory. By 2024, the logic had not materialized into margin performance: TRANZACT's economics were structurally different from WTW's core Health, Wealth & Career and Risk & Broking segments. The business required high customer acquisition costs, operated in a highly competitive direct-to-consumer Medicare market, and generated margins that diluted rather than enhanced the parent's adjusted operating margin.
The $632.4 million sale price to GTCR and Recognize in October 2024 is partly about the cash — $632M is a meaningful capital return in a $9.9B revenue business — but more importantly it is about the denominator. Removing TRANZACT from the adjusted operating margin calculation improves WTW's margin from 23.9% to 24.4% not because the underlying operations improved, but because the dilutive revenue is no longer in the base. This is portfolio discipline as margin management: identifying and exiting the segments where WTW's operating model does not deliver competitive margins, rather than managing them indefinitely at sub-optimal performance.
The 190 basis point improvement from the FY2022 baseline to FY2024 reflects three years of Transformation program execution plus the TRANZACT exit. The R&B segment's 33.5% operating margin in FY2024 — well above WTW's blended 23.9% — shows where WTW's structural margin advantage resides: in the Risk & Broking business where its scale, specialty capabilities, and carrier relationships create pricing power. HWC's lower margin reflects the consulting economics of that segment. The portfolio simplification argument is that WTW's margin is higher and more defensible when it is not carrying a direct-to-consumer operation with fundamentally different economic characteristics.
Transformation Program Driving Margin Expansion Through Operational Consolidation
Brown & Brown: Decentralized Operating Model Driving Best-in-Class Margins
Arthur J. Gallagher: Serial Acquisition Engine Driving Scale and Margin Expansion